Teva recalls ketamine injections
FDA announces voluntary recall of Teva's Ketamine Hydrochloride Injection.
St. Joseph, Mo.
-- Teva Animal Health expanded its voluntary recall of its Ketamine Hydrochloride Injection, according to the U.S. Food and Drug Administration (FDA).
The recall, issued Dec. 21, affects USP CIII 100 mg/mL in 10 mL vials for all lot numbers within their expiration dates at the veterinary level, FDA says. The injection has previously been recalled at the distributor level. The recall expanded because of "an increased trend in serious adverse events associated with this product," FDA reports in a prepared statement.
Veterinarians should stop using the recalled ketamine injectable immediately and return all existing products to the distributor, FDA says.
At presstime, Teva Animal Health did not return telephone calls seeking comment.
Veterinarians can direct questions about the recall to Teva at (800) 759-3664 between the hours of 8 a.m. and 5 p.m. CST.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More
